Standard
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. / Monforte, Antonella d'Arminio; Reiss, Peter; Nielsen, Lene Ryom; El-Sadr, Wafaa; Dabis, Francois; De Wit, Stephane; Worm, Signe W; Law, Mathew G; Weber, Rainer; Kirk, Ole; Pradier, Christian; Phillips, Andrew N; Lundgren, Jens D; Sabin, Caroline A.
I:
AIDS (London, England), Bind 27, Nr. 3, 28.01.2013, s. 407-15.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Harvard
Monforte, ADA, Reiss, P
, Nielsen, LR, El-Sadr, W, Dabis, F, De Wit, S, Worm, SW, Law, MG, Weber, R
, Kirk, O, Pradier, C, Phillips, AN
, Lundgren, JD & Sabin, CA 2013, '
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events',
AIDS (London, England), bind 27, nr. 3, s. 407-15.
https://doi.org/10.1097/QAD.0b013e32835b2ef1
APA
Monforte, A. DA., Reiss, P.
, Nielsen, L. R., El-Sadr, W., Dabis, F., De Wit, S., Worm, S. W., Law, M. G., Weber, R.
, Kirk, O., Pradier, C., Phillips, A. N.
, Lundgren, J. D., & Sabin, C. A. (2013).
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events.
AIDS (London, England),
27(3), 407-15.
https://doi.org/10.1097/QAD.0b013e32835b2ef1
Vancouver
Monforte ADA, Reiss P
, Nielsen LR, El-Sadr W, Dabis F, De Wit S o.a.
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events.
AIDS (London, England). 2013 jan. 28;27(3):407-15.
https://doi.org/10.1097/QAD.0b013e32835b2ef1
Author
Monforte, Antonella d'Arminio ; Reiss, Peter ; Nielsen, Lene Ryom ; El-Sadr, Wafaa ; Dabis, Francois ; De Wit, Stephane ; Worm, Signe W ; Law, Mathew G ; Weber, Rainer ; Kirk, Ole ; Pradier, Christian ; Phillips, Andrew N ; Lundgren, Jens D ; Sabin, Caroline A. / Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. I: AIDS (London, England). 2013 ; Bind 27, Nr. 3. s. 407-15.
Bibtex
@article{0d5165de51b44aec9f753c7282d4b32d,
title = "Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events",
abstract = "To investigate whether there is any association between exposure to atazanavir (ATV), either when boosted or unboosted by ritonavir, and myocardial infarction (MI) or stroke within the D:A:D: Study.",
keywords = "Adult, Aged, Australia, Comorbidity, Drug Therapy, Combination, Europe, Female, Follow-Up Studies, HIV Infections, HIV Protease Inhibitors, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Oligopeptides, Prospective Studies, Pyridines, Risk Factors, Ritonavir, Stroke, Time Factors, Treatment Outcome, United States, Viral Load",
author = "Monforte, {Antonella d'Arminio} and Peter Reiss and Nielsen, {Lene Ryom} and Wafaa El-Sadr and Francois Dabis and {De Wit}, Stephane and Worm, {Signe W} and Law, {Mathew G} and Rainer Weber and Ole Kirk and Christian Pradier and Phillips, {Andrew N} and Lundgren, {Jens D} and Sabin, {Caroline A}",
year = "2013",
month = jan,
day = "28",
doi = "10.1097/QAD.0b013e32835b2ef1",
language = "English",
volume = "27",
pages = "407--15",
journal = "AIDS",
issn = "1350-2840",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "3",
}
RIS
TY - JOUR
T1 - Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events
AU - Monforte, Antonella d'Arminio
AU - Reiss, Peter
AU - Nielsen, Lene Ryom
AU - El-Sadr, Wafaa
AU - Dabis, Francois
AU - De Wit, Stephane
AU - Worm, Signe W
AU - Law, Mathew G
AU - Weber, Rainer
AU - Kirk, Ole
AU - Pradier, Christian
AU - Phillips, Andrew N
AU - Lundgren, Jens D
AU - Sabin, Caroline A
PY - 2013/1/28
Y1 - 2013/1/28
N2 - To investigate whether there is any association between exposure to atazanavir (ATV), either when boosted or unboosted by ritonavir, and myocardial infarction (MI) or stroke within the D:A:D: Study.
AB - To investigate whether there is any association between exposure to atazanavir (ATV), either when boosted or unboosted by ritonavir, and myocardial infarction (MI) or stroke within the D:A:D: Study.
KW - Adult
KW - Aged
KW - Australia
KW - Comorbidity
KW - Drug Therapy, Combination
KW - Europe
KW - Female
KW - Follow-Up Studies
KW - HIV Infections
KW - HIV Protease Inhibitors
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Myocardial Infarction
KW - Oligopeptides
KW - Prospective Studies
KW - Pyridines
KW - Risk Factors
KW - Ritonavir
KW - Stroke
KW - Time Factors
KW - Treatment Outcome
KW - United States
KW - Viral Load
U2 - 10.1097/QAD.0b013e32835b2ef1
DO - 10.1097/QAD.0b013e32835b2ef1
M3 - Journal article
C2 - 23291539
VL - 27
SP - 407
EP - 415
JO - AIDS
JF - AIDS
SN - 1350-2840
IS - 3
ER -